At the 6th World Symposium on Pulmonary Hypertension (WSPH) held in Nice in 2018, PH classification was updated. A major change in the classification was that PH and pulmonary arterial hypertension (PAH) were defined as mean pulmonary arterial pressure of 20 mmHg. Additionally Calcium channel blocker responder for long period was added to PAH classification. Furthermore, the subgroup PAH with overt features of venous/capillaries (PVOD/PCH) involvement was added to the updated PAH classification. This manuscript provides an outline of the Nice PH Classification 2018 and reviews the relationship between the genetic basis and clinical presentation of PAH and the difficulty of treating childhood PAH. In addition, it describes the author s own research in this field.

